TGFBR2 and cancer: However, TβRII is the common factor in all TGFβsignaling, and we found that it is susceptible to pharmacologicaland genetic perturbations that inhibit TGFβ-dependent EMT ofNSCLC cells.59,60 Several lines of evidence suggestextraordinary roles of TβRII in cancer progression and aggressiveness.23−25